Non-small cell lung cancer or NSCLC is the more common lung cancer that occurs in patients but is not as fast growing as small cell lung cancer or SCLC. Malignant cancerous cells appear in lungs and the lymph nodes, and depending on the stage and severity, different treatments are suggested, including chemotherapy for non-small cell lung cancer.
In NSCLC, there are three types that are typically diagnosed:
There are five stages of NSCLC. Depending on which stage your cancer is in helps decide the treatment you will get.
Surgery is common in the treatment process for NSCLC. Surgery is used for stages 0 and I. Surgery can be done when the cancer is still contained in the lungs. Surgeries involve removal of lobes of the lung, part of the lung or an entire lung, all of which depends on the spread of the cancer.
The other treatment for lung cancer is usually a combination of chemotherapy and radiation. Chemotherapy is a treatment that uses rays to kill cancer from the outside. Only chemotherapy is used if the patient is in stage IV of NSCLC.
Chemotherapy, along with radiation, is also given before surgery. This treatment is termed as neoadjuvant therapy. Chemotherapy can be given even after surgery to kill off any potential cancer cells that surgery may not have removed.
The survival rate till stage II is very high. Chemotherapy in NSCLC has shown to prolong life quite a bit and is a common method of treatment.
For some stages of NSCLC, chemotherapy is given as part of the first line treatment. Recent research shows more doctors prefer giving it even if the cancer in below stage II (not serious enough for chemotherapy).
The debate whether chemotherapy should be used in first-line treatment, second-line treatment or even third-line treatment, as a preventive step; continues. If doctors use chemotherapy in stage IV NSCLC, then the chances of survival tend to be low. But if the cancer is discovered in stage IV, there is anyway little a doctor can do. So whether a doctor should use chemotherapy as first-line treatment is still being debated upon. Patients who are going to be given chemotherapy as third-line treatment, they should also be told about the possible dangers.
Reference